Find therapies in clinical trials near you

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

A Study Comparing Nipocalimab and Efgartigimod for Adults with Generalized Myasthenia Gravis

A Study Comparing Nipocalimab and Efgartigimod for Adults with Generalized Myasthenia Gravis

Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Study on Nipocalimab for Adults with Generalized Myasthenia Gravis

Study on Nipocalimab for Adults with Generalized Myasthenia Gravis

Study of Nipocalimab in Pregnant Women at Risk of Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Study of Nipocalimab in Pregnant Women at Risk of Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Study on Nipocalimab for Reducing Risk of Fetal and Neonatal Alloimmune Thrombocytopenia in At-risk Pregnancies

Study on Nipocalimab for Reducing Risk of Fetal and Neonatal Alloimmune Thrombocytopenia in At-risk Pregnancies

Study on Nipocalimab for Children Aged 2-17 with Generalized Myasthenia Gravis

Study on Nipocalimab for Children Aged 2-17 with Generalized Myasthenia Gravis

Study on the Effectiveness and Safety of Nipocalimab for Adults with Moderate to Severe Sjögren's Disease

Study on the Effectiveness and Safety of Nipocalimab for Adults with Moderate to Severe Sjögren's Disease

Safety, Tolerability, PK and PD of Nipocalimab (JNJ-80202135) Subcutaneous Injection via Syringe or Prefilled Autoinjector in Healthy Volunteers

Study on Nipocalimab for Adults with Active Inflammatory Muscle Diseases

Study on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia

Study on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia

Study on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Study on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)